Sponsor:
Compass Therapeutics
Code:
NCT06150664
Conditions
Non Small Cell Lung Cancer
Triple Negative Breast Cancer
Hodgkin Lymphoma
Head and Neck Squamous Cell Carcinoma
Malignant Melanoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CTX-8371
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-19. This information was provided to ClinicalTrials.gov by Compass Therapeutics on 2025-01-03.